TY - JOUR
T1 - Formulation, characterization, evaluation and in vitro study of transfersomal gel medroxyprogesterone acetate for transdermal drug delivery
AU - Iskandarsyah, null
AU - Masrijal, Camelia Dwi Putri
AU - Harmita,
N1 - Funding Information:
The authors acknowledge to Universitas Indonesia for financial support: Hibah PITTA No: NKB:0476/UN2.R3.1/HKP.05.00/2019 and Hibah Q1Q2 No: NKB-0199/UN2.R3.1/ HKP.05.00/2019.
Publisher Copyright:
© 2020 Global Research Online. All rights reserved.
PY - 2020/10/7
Y1 - 2020/10/7
N2 - A hormonal contraception progestin such as medroxyprogesterone acetate (MPA) is used to helps regulate ovulation thus as a part of contraception hormone therapy as a method of birth control. This study aimed to formulate, characterized, evaluated transfersomal gel containing medroxyprogesterone acetate and to increased subcutaneous penetration of medroxyprogesterone acetate. In this research, three transfersomes formulas were prepared and optimized, e.g. F1, F2 and F3 with phosphatidylcholine: tween 80 concentration were 90:10; 85:15; and 75:25, respectively. F2 was the best formula with the highest entrapment efficiency 81.20±0.42 %, Average 81.35 ±0.78 nm, morphology of vesicles were spheres, indeks polidispersity 0.198±0.012 and zeta potential was-34.83±0.64 mV. The transpersonal gel (FGT) containing F2, and non-transpersonal gel containing MPA in methanol(FG) were prepared. In vitro penetration test were conducted to both of them using Franz Diffusion cells. Analysis of medroxyprogesterone acetate used a high performance liquid chromatographic (HPLC) method with an ultraviolet detector on reversed-phase C18, 5µm; 150 x 4.6 mmcolumn; using acetonitrile-0.1% formic acid (60:40/v:v) and was detected at a wavelength of 240 nm with flow rate at 1.0 mL/min. Gel stability evaluation results showed that FGT was better than FG on pH stability, viscosity and rheological properties. Based on in vitro penetration study, cumulative subcutaneous penetration of medroxyprogesterone acetate from FGT was 2356.45 ± 197.73 ng.cm−2 and from FG 359.15 ± 13.60 ng.cm−2, respectively. Flux value for FGT and FG were 112.77 ± 6,47 ng.cm−2 .hr−1and 17.99 ± 4.81 ng.cm−2 .hr−1, respectively. It could be concluded that transfersomal gel medroxyprogesterone acetate for transdermal drug delivery increased cumulative transdermal penetration of medroxyprogesterone acetate by six times more than non-transfersomal gel dosage form.
AB - A hormonal contraception progestin such as medroxyprogesterone acetate (MPA) is used to helps regulate ovulation thus as a part of contraception hormone therapy as a method of birth control. This study aimed to formulate, characterized, evaluated transfersomal gel containing medroxyprogesterone acetate and to increased subcutaneous penetration of medroxyprogesterone acetate. In this research, three transfersomes formulas were prepared and optimized, e.g. F1, F2 and F3 with phosphatidylcholine: tween 80 concentration were 90:10; 85:15; and 75:25, respectively. F2 was the best formula with the highest entrapment efficiency 81.20±0.42 %, Average 81.35 ±0.78 nm, morphology of vesicles were spheres, indeks polidispersity 0.198±0.012 and zeta potential was-34.83±0.64 mV. The transpersonal gel (FGT) containing F2, and non-transpersonal gel containing MPA in methanol(FG) were prepared. In vitro penetration test were conducted to both of them using Franz Diffusion cells. Analysis of medroxyprogesterone acetate used a high performance liquid chromatographic (HPLC) method with an ultraviolet detector on reversed-phase C18, 5µm; 150 x 4.6 mmcolumn; using acetonitrile-0.1% formic acid (60:40/v:v) and was detected at a wavelength of 240 nm with flow rate at 1.0 mL/min. Gel stability evaluation results showed that FGT was better than FG on pH stability, viscosity and rheological properties. Based on in vitro penetration study, cumulative subcutaneous penetration of medroxyprogesterone acetate from FGT was 2356.45 ± 197.73 ng.cm−2 and from FG 359.15 ± 13.60 ng.cm−2, respectively. Flux value for FGT and FG were 112.77 ± 6,47 ng.cm−2 .hr−1and 17.99 ± 4.81 ng.cm−2 .hr−1, respectively. It could be concluded that transfersomal gel medroxyprogesterone acetate for transdermal drug delivery increased cumulative transdermal penetration of medroxyprogesterone acetate by six times more than non-transfersomal gel dosage form.
KW - Characterization
KW - Formulation
KW - Gel
KW - In Vitro Study
KW - Medroxyprogesterone Acetate
KW - Transdermal
KW - Transfersome
UR - http://www.scopus.com/inward/record.url?scp=85092236540&partnerID=8YFLogxK
U2 - 10.26452/ijrps.v11i4.3159
DO - 10.26452/ijrps.v11i4.3159
M3 - Article
AN - SCOPUS:85092236540
SN - 0975-7538
VL - 11
SP - 5373
EP - 5381
JO - International Journal of Research in Pharmaceutical Sciences
JF - International Journal of Research in Pharmaceutical Sciences
IS - 4
ER -